Rémi Vatan

Corrigendum to “A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study” [Clin Microbiol Infect 28 (2) (2022) 298.e9–e15]

Pierre Fillâtre, Marie-José Dufour, Sylvie Behillil, Rémi Vatan et autres

fr (code pays fourni par la source)

Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome

Romain Stammler, Alexandre Vallée, Julien Rohmer, Nathalie Grardel et autres

fr, us, sg, gb, re (code pays fourni par la source)

Long-term neuro-functional disability in adult patients with community-acquired bacterial meningitis

Souade Akroum, Sarah Tubiana, T. de Broucker, Nathalie Dournon et autres

fr, gp, nc (code pays fourni par la source)

A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study

Pierre Fillâtre, Marie-José Dufour, Sylvie Behillil, Rémi Vatan et autres

fr (code pays fourni par la source)

A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality

Pierre Fillâtre, Marie-José Dufour, Sylvie Behillil, Rémi Vatan et autres

ABSTRACT Background In early January 2021, an outbreak of nosocomial cases of COVID-19 emerged in Western France, with RT-PCR tests repeatedly negative on nasopharyngeal samples but positive on lower respiratory tract samples. Whole genome sequencing (WGS) revealed a new variant, currently defining …

fr (code pays fourni par la source)

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

Vincent Dubée, Pierre‐Marie Roy, Bruno Vielle, Elsa Parot‐Schinkel et autres

OBJECTIVES: To determine whether hydroxychloroquine decreases the risk of adverse outcome in patients with mild to moderate coronavirus disease 2019 (COVID-19) at high risk of worsening. METHODS: We conducted a multicentre randomized double-blind placebo-controlled trial evaluating hydroxychloroquine in COVID-19 patients with at …

fr (code pays fourni par la source)

A New SARS-CoV-2 Variant Poorly Detected by RT-PCR on Nasopharyngeal Samples, with High Lethality

Pierre Fillâtre, Marie José Dufour, Sylvie Behillil, Rémi Vatan et autres

fr, gb, us (code pays fourni par la source)

Assessment of drug–drug interaction in an elderly human immunodeficiency virus population: Comparison of 3 expert databases

Anne‐Lise Ruellan, Delphine Bourneau‐Martin, Caroline Joyau, Solène Sécher et autres

AIMS: Polypharmacy increase the risk of drug-drug interactions (DDIs) in the elderly population living with human immunodeficiency virus (HIV). Several expert databases can be used to evaluate DDIs. The aim of the study was to describe actual DDIs between antiretroviral drugs and …

fr, vn (code pays fourni par la source)

HIV-infected patients aged above 75 years

C. Bernaud, Solène Sécher, Christophe Michau, Philippe Van de Perre et autres

ca, fr (code pays fourni par la source)

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Caroline M. Charlier, Élodie Perrodeau, Alexandre Leclercq, Benoît Cazenave et autres

BACKGROUND: Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its clinical features and prognostic factors. METHODS: MONALISA was a national prospective observational cohort study. We enrolled eligible cases declared to …

fr, us (code pays fourni par la source)

Prévalence et facteurs de risque de troubles du sommeil dans une grande cohorte de patients adultes vivant avec le VIH (PVVIH)

Sylvie De La Tullaye, Laurène Leclair‐Visonneau, Solène Pineau, Jean-Marie Chennebault et autres

fr (code pays fourni par la source)

Prevalence and Risk Factors of Sleep Disturbance in a Large HIV-Infected Adult Population

Clotilde Allavena, Thomas Guimard, Éric Billaud, Sylvie de la Tullaye et autres

fr (code pays fourni par la source)